Astrazeneca Share News (AZN)

TOP NEWS: EU approves AstraZeneca's Forxiga for chronic heart failure

(Alliance News) - AstraZeneca PLC on Tuesday announced that the EU has approved its drug Forxiga for the treatment of symptomatic chronic heart failure.

UK stocks slip as rate hike worries grip investors

Global sentiment dented by worries over higher interest rates

*

Drug companies face COVID cliff in 2023 as sales set to plummet

NEW YORK, Feb 6 (Reuters) - Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their windfalls wisely.

Sanofi forecasts moderate profit growth on Dupixent demand

Sees "low single digit" percentage core EPS growth, FX adjusted

*

UK earnings, trading statements calendar - next 7 days

TOP NEWS: AstraZeneca's, Amgen's Tezspire pre-filled pen wins approval

(Alliance News) - AstraZeneca PLC and Amgen Inc on Thursday said their severe asthma drug Tezspire has been approved in the form of a pre-filled pen by the US Food & Drug Administration for self-administration for people aged 12 and over.

Roche warns 2023 profits will fall on $5 bln COVID sales hit

2023 outlook weaker than expected - analysts

*

Sector movers: Miners and Big Pharma drag

(Sharecast News) - Miners were again the main drag on the stock market on a mixed day for industrial metals' prices as traders waited on the Federal Reserve's interest rate decision and policy guidance on Wednesday evening.

FTSE 100 falls ahead of Fed decision; healthcare shares drag

Fed interest rate decision due 1900 GMT

*

GSK beats expectations, shingles vaccine bolsters outlook

Q4 profit and sales figures beat forecasts

*

Share buybacks in Europe as significant as in U.S.

STOXX 600 down around 1%

*

Banks: six reasons to be overweight

STOXX 600 down 1%

*

STOXX slides

STOXX 600 down 0.5%

*

European shares seen lower

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

EUROPEAN SHARES SEEN LOWER (0730 GMT)

Mind the gap

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

MIND THE GAP (0656 GMT)